Dinaciclib in Treating Patients With Stage IV Melanoma

Clinical trial NCT00937937 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00937937
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acral Lentiginous Melanoma Cutaneous Nodular Melanoma Lentigo Maligna Melanoma Low-CSD Melanoma Mucosal Melanoma Recurrent Melanoma Stage IV Cutaneous Melanoma AJCC v6 and v7

Start date: 2009-07-01
Primary completion: 2013-10-22
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.